Klabunde et al developed a comorbidity index for females with breast cancer based on analysis of Medicare data. This can help identify a patient who may benefit from more aggressive management. The authors are from the National Cancer Institute in Bethesda, Maryland.
Data was available from:
(1) inpatient Medicare claims
(2) physician Medicare claims
This data was analyzed to determine coefficients for common comorbid conditions.
Comorbid Condition |
Inpatient Claim Coefficients |
Physician Claim Coefficients |
cerebrovascular disease |
-0.09 |
1.10 |
chronic pulmonary disease |
0.83 |
0.84 |
congestive heart failure |
0.76 |
0.74 |
dementia |
0.14 |
1.07 |
diabetes mellitus, uncomplicated |
0.52 |
0.65 |
diabetes with complications |
0.64 |
0.36 |
liver disease, mild |
1.19 |
1.63 |
myocardial infarction, acute |
0.05 |
-0.99 |
myocardial infarction, old |
1.00 |
0 |
paralysis |
1.23 |
-0.08 |
peptic ulcer disease |
0.03 |
-0.65 |
peripheral vascular disease |
0.23 |
0.75 |
renal disease, moderate to severe |
1.34 |
1.20 |
rheumatologic disease |
0.92 |
-0.45 |
where:
• The coefficient for moderate or severe liver disease is not given. It should be higher than for mild liver disease, but the coefficient for mild disease will be used until a better value is known.
For each type of claim (inpatient or physician), identify all of the comorbid conditions present and list the corresponding coefficients.
sum of coefficients =
= SUM(coefficients for all comorbid conditions present)
chances of patient dying within 2 years when compared to a patient of similar age with similar disease but with no comorbid condition =
= EXP(sum of coefficients)
Purpose: To estimate the impact of comorbid conditions on survival in a female with breast cancer using the comorbidity index of Klabunde et al.
Objective: selection, comorbid conditions
ICD-10: C50,